Table 1.
Author/Series | Type of Relapse | Treatment at Relapse | Outcome |
---|---|---|---|
Ferrari et al, 20122 - Italian AIEOP-STSC Retrospective national, multi-center study (period: 1979–2006) Number of cases: 44 (initially non-metastatic) Age < 21 years |
15 local relapse, 22 metastatic, 7 both median time to relapse 20 months | 50% had chemotherapy (5 cases had ifosfamide-doxorubicin, 5 high-dose ifosfamide, 5 carboplatin-etoposide, 3 cisplatin-based regimens, 3 dacarbazine); 61% had surgery; 25% had radiotherapy | 5-year and 10-year OS 30% and 21%; the most significant factors associated with survival were the time to relapse and the type of recurrence: pts with local and late relapse had 10-year OS of 68.6% |
Soole et al, 20144 - French SFCE Retrospective national, multi-center study (period: 1988–2008) Number of cases: 37 (initially non-metastatic) Age 3–18 years, median 12 |
27 local relapse, 10 metastatic median time to relapse 24 months |
75% had surgery; 73% had chemotherapy (49% ifosfamide-based regimen); 49% had radiotherapy |
5-year EFS 33%, 5-year OS 42%; primary extremity tumor, age less than 12 years and local relapse were associated with relatively better outcome |
Scheer et al, 201659 - German CWS Retrospective national, multi-center study (period: 1981–2010) Number of cases: 52 (initially non-metastatic) Age 1–21 years, median 14 |
22 local relapse, 24 metastatic, 6 both median time to relapse 2.5 years | 62% had chemotherapy; 69% had surgery; 21% had radiotherapy | 5-year EFS 26%, 5-year OS 46%; prognostic factors: surgery feasibility, local relapse |
Abbreviations: pts, patients; OS, overall survival; EFS, event-free survival; AIEOP-STSC, Associazione italiana ematologia oncologia pediatrica - soft tissue sarcoma committee (Italian Cooperative Group); SFCE, Société Française des Cancers et des leucémies de l’Enfant et de l’adolescent (French pediatric hematology oncology society); CWS, Cooperative weichteilsarkomen studiengruppe (German soft tissue sarcoma cooperative group).